Article Text

Download PDFPDF
Overcoming challenges in the implementation of clinical practice guidelines in China
  1. Dongmei Zhong1,2,
  2. Nan Yang3,4,5,6,
  3. Yaolong Chen3,4,5,6,
  4. Dong (Roman) Xu7,8
  1. 1School of Public Health, Southern Medical University, Guangzhou, Guangdong Province, China
  2. 2Acacia Lab for Implementation Science, School of Health Management, Southern Medical University, Guangzhou, Guangdong Province, China
  3. 3Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China
  4. 4Research Unit of Evidence-Based Evaluation and Guidelines (2021RU017), Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China
  5. 5WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou, Gansu, China
  6. 6Institute of Health Data Science, Lanzhou University, Lanzhou, Gansu, China
  7. 7Acacia Lab for Implementation Science, Dermatology Hospital and School of Health Management, Southern Medical University, Guangzhou, Guangdong Province, China
  8. 8Southern Medical University Institute for Global Health, School of Public Health, Southern Medical University, Guangzhou, Guangdong Province, China
  1. Correspondence to Professor Dong (Roman) Xu; romanxu{at}i.smu.edu.cn; Professor Yaolong Chen; chevidence{at}lzu.edu.cn

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Introduction

Clinical practice guidelines (CPGs) are ‘systematically developed statements to assist practitioner and patient decisions about appropriate healthcare for specific circumstances’.1 The implementation of guidelines can help optimise resource utilisation, reduce variations in clinical practice and identify and apply evidence-based recommendations safely and effectively.2 In China, the number of guidelines is increasing annually, while low adherence remains a significant challenge. Low adherence not only wastes healthcare resources but also allows preventable deaths to occur. Addressing the poor implementation of guidelines in China is urgent.

Implementation research, which is the scientific study to promote evidence-based practices into routine practice,3 may be feasible to improve guideline adherence. For example, by finding the barriers and facilitators for the guideline implementation, the implementation strategy is designed accordingly. However, in China, which has a large population and area, the implementation strategy adopted in a small area for a specific context may only be effective in a certain region, but it is difficult to work in the whole country.2 Therefore, it is necessary to pay attention to the intrinsic factors of the guidelines and optimise the guidelines from the development of the guidelines, so as to improve the guideline implementability. This article provides a brief overview of the quantity, quality and implementation of CPGs in China, along with suggestions for future directions, offering basic information for scholars to understand the implementation of CPGs in China.

Weak implementation status in China

The number of published CPGs in China is rising year by year. This brisk expansion in numbers may reflect the maturation of the practice of producing CPGs and, on the other hand, indicate the government and academic institutions’ role in recognising guideline development within their metric systems. Such recognition provides potent incentives for the prolific creation of guidelines.

Historically, the …

View Full Text

Footnotes

  • DZ and NY contributed equally.

  • Contributors DZ was responsible for the selection of the thesis and the writing of the first draft of the thesis; NY and YC participated in the revision and text finishing of the first draft; DRX is responsible for structural design, data and information review, revision, quality control and review of the first draft of the paper.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.